Seer (SEER) Non-Current Assets (2020 - 2026)

Seer (SEER) recorded quarterly Non-Current Assets of $90.5 million in Q1 2026, down 4.24% quarter-over-quarter from $94.5 million in Q4 2025, and down 1.58% on a YoY basis from $92.0 million in Q1 2025.

Seer (SEER) Non-Current Assets (2020 - 2026) Analysis & Trends

Seer's Non-Current Assets history runs 7 years deep, the most recent figure standing at $90.5 million for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 1.58% year-over-year to $90.5 million; the TTM figure through Mar 2026 stood at $376.2 million (down 12.82% YoY), while the FY2025 annual figure was $94.5 million, down 16.53% from the prior year.
  • Non-Current Assets was $90.5 million for Q1 2026 at Seer, down from $94.5 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $125.8 million in Q2 2023 to a low of $49.5 million in Q2 2022.
  • Historically, Non-Current Assets has averaged $91.9 million across 5 years, with a median of $96.8 million in 2025.
  • Biggest YoY gain for Non-Current Assets was 640.58% in 2022; the steepest drop was 58.45% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $52.9 million in 2022, then soared by 99.74% to $105.8 million in 2023, then climbed by 7.11% to $113.3 million in 2024, then decreased by 16.53% to $94.5 million in 2025, then decreased by 4.24% to $90.5 million in 2026.
  • The last three Non-Current Assets figures came in at $90.5 million (Q1 2026), $94.5 million (Q4 2025), and $94.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 62,953.78
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 289.41 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 4.56 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 30.30 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 14.75 Bn
9 Abivax 94.37 Bn 94.37 Bn - 39.71 Mn
10 Seer 99.67 Mn 99.67 Mn 982,000.00 90.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 90.54 Mn
Dec 31, 2025 94.55 Mn
Sep 30, 2025 94.25 Mn
Jun 30, 2025 96.85 Mn
Mar 31, 2025 91.99 Mn
Dec 31, 2024 113.27 Mn
Sep 30, 2024 119.32 Mn
Jun 30, 2024 106.92 Mn
Mar 31, 2024 97.81 Mn
Dec 31, 2023 105.76 Mn
Sep 30, 2023 98.73 Mn
Jun 30, 2023 125.81 Mn
Mar 31, 2023 105.41 Mn
Dec 31, 2022 52.95 Mn
Sep 30, 2022 49.74 Mn
Jun 30, 2022 49.54 Mn
Mar 31, 2022 69.63 Mn
Dec 31, 2021 127.44 Mn
Sep 30, 2021 13.57 Mn
Jun 30, 2021 11.72 Mn